| Autor: |
Khoshtabiat L; Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran E-mail : majid.mahdavi@tabrizu.ac.ir., Mahdavi M, Dehghan G, Rashidi MR |
| Jazyk: |
angličtina |
| Zdroj: |
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2016; Vol. 17 (9), pp. 4267-4273. |
| Abstrakt: |
Previous studies suggested that dithio-carbamates are potent apoptosis and anti-apoptosis inducing agents in various cancer cells. Here, the anti-proliferative and apoptosis inducing effects of a new derivative (2-NDC) from the dithio-carbamate family was examined in human leukemia K562 cells. We use thiazolyl blue tetrazolium bromide (MTT) to measure viability and cell growth inhibition. The 2-NDC showed effects on viability in a dose and time-dependent manner, inhibiting proliferation at concentrations of 10-30 μM after 24-48 hours of treatment and increasing values after 72 hours at 40-120 μM. The cytotoxic effect of the compound was calculated with an IC50 of 30 μM after 24-hour. Apoptosis induction was confirmed by acridine orange-ethidium bromide (AO/EtBr) staining, DNA fragmentation assay, flow cytometric assessment and also caspase-3 activation assay. Furthermore, enzymes level such as superoxide dismutase (SOD) and catalase (CAT) involved in oxidative stress were evaluated. The results of this study demonstrated insignificant increase of intracellular ROS levels for 24 hours and reduction after 48-72 hours. In addition to reduction of intracellular thiol, caspase-3 like activity was also decreased in a time-dependent manner in cells treated with 2-NDC. Thus 2-NDC can be considered as a good candidate for further pharmaceutical evaluations. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
